Interestingly, we then analyzed the downstream signaling pathway RBCK1 was possibly involved in and found that RBCK1 inactivation significantly promotes receptor tyrosine kinases (RTK) pathway in RCC samples from TCGA (p < 0.001; Figure 10E). The gene discussed is RBCK1; the disease is renal cell carcinoma.